Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1987 2
1988 3
1990 4
1991 2
1993 4
1996 5
1997 8
1998 4
1999 9
2000 10
2001 19
2002 14
2003 12
2004 17
2005 21
2006 15
2007 21
2008 19
2009 27
2010 24
2011 38
2012 36
2013 29
2014 35
2015 37
2016 26
2017 32
2018 25
2019 21
2020 23
2021 17
2022 14
2023 7
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

498 results

Results by year

Filters applied: . Clear all
Page 1
Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A, Zerbini CA, Milmont CE, Chen L, Maddox J, Meisner PD, Libanati C, Grauer A. Cosman F, et al. Among authors: adachi jd. N Engl J Med. 2016 Oct 20;375(16):1532-1543. doi: 10.1056/NEJMoa1607948. Epub 2016 Sep 18. N Engl J Med. 2016. PMID: 27641143 Free article. Clinical Trial.
Denosumab: mechanism of action and clinical outcomes.
Hanley DA, Adachi JD, Bell A, Brown V. Hanley DA, et al. Among authors: adachi jd. Int J Clin Pract. 2012 Dec;66(12):1139-46. doi: 10.1111/ijcp.12022. Epub 2012 Sep 12. Int J Clin Pract. 2012. PMID: 22967310 Free PMC article. Review.
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
Miller PD, Adachi JD, Albergaria BH, Cheung AM, Chines AA, Gielen E, Langdahl BL, Miyauchi A, Oates M, Reid IR, Santiago NR, Vanderkelen M, Wang Z, Yu Z. Miller PD, et al. Among authors: adachi jd. J Bone Miner Res. 2022 Aug;37(8):1437-1445. doi: 10.1002/jbmr.4563. Epub 2022 May 20. J Bone Miner Res. 2022. PMID: 35466448 Free PMC article. Clinical Trial.
Glucocorticoid induced osteoporosis.
Hu K, Adachi JD. Hu K, et al. Among authors: adachi jd. Expert Rev Endocrinol Metab. 2019 Jul;14(4):259-266. doi: 10.1080/17446651.2019.1617131. Epub 2019 May 16. Expert Rev Endocrinol Metab. 2019. PMID: 31094232 Review.
Zoledronic acid and clinical fractures and mortality after hip fracture.
Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S; HORIZON Recurrent Fracture Trial. Lyles KW, et al. Among authors: adachi jd. N Engl J Med. 2007 Nov 1;357(18):1799-809. doi: 10.1056/NEJMoa074941. Epub 2007 Sep 17. N Engl J Med. 2007. PMID: 17878149 Free PMC article. Clinical Trial.
Romosozumab in the treatment of osteoporosis.
Kobza AO, Papaioannou A, Lau AN, Adachi JD. Kobza AO, et al. Among authors: adachi jd. Immunotherapy. 2020 Sep;12(13):965-981. doi: 10.2217/imt-2020-0158. Epub 2020 Aug 5. Immunotherapy. 2020. PMID: 32752907 Review.
Understanding and Managing Corticosteroid-Induced Osteoporosis.
Kobza AO, Herman D, Papaioannou A, Lau AN, Adachi JD. Kobza AO, et al. Among authors: adachi jd. Open Access Rheumatol. 2021 Jul 2;13:177-190. doi: 10.2147/OARRR.S282606. eCollection 2021. Open Access Rheumatol. 2021. PMID: 34239333 Free PMC article. Review.
Corticosteroid-induced osteoporosis.
Adachi JD. Adachi JD. Int J Fertil Womens Med. 2001 Jul-Aug;46(4):190-205. Int J Fertil Womens Med. 2001. PMID: 11563829 Review.
498 results